RNA-binding protein Raly (RALY) (Middle Region) Peptide
RALY
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN982638
Aperçu rapide pour RNA-binding protein Raly (RALY) (Middle Region) Peptide (ABIN982638)
Antigène
Raly (RALY)
(RNA-binding protein Raly (RALY))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Séquence
- TQIKSNIDAL LSRLEQIAAE QKANPDGKKK GDGGGAGGGG GGGGSGGGGS
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-RALY Antibody(ARP33107_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- Raly (RALY) (RNA-binding protein Raly (RALY))
-
Sujet
-
In infectious mononucleosis, anti-EBNA-1 antibodies are produced which cross-react with multiple normal human proteins. The cross-reactivity is due to anti-gly/ala antibodies that cross-react with host proteins containing configurations like those in the EBNA-1 repeat. One such antigen is RALY which is a member of the heterogeneous nuclear ribonucleoprotein gene family.
Alias Symbols: HNRPCL2, MGC117312, P542
Protein Interaction Partner: PCBP1,PIK3CD,SPG7,WDR62,SPG7,USP45,WDR62
Protein Size: 290 -
Poids moléculaire
- 30 kDa
-
ID gène
- 22913
-
NCBI Accession
- NM_007367, NP_031393
Antigène
-
Vous êtes ici:
